Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mosliciguat in Pulmonary Hypertension Associated With Interstitial Lung Disease
NCT07816185Phase 3Recruiting
- Sponsor
- Pulmovant
- Start
- Aug 2026
- Primary completion
- Jan 2029
- Countries
- 1
01
Overview
A Phase 3 trial of mosliciguat in pulmonary hypertension (PH), sponsored by Pulmovant. Started Aug 2026; status: recruiting.
02
Drugs
mosliciguat
03
Conditions
pulmonary hypertension (PH)
Beyond the preview
Go deeper on NCT07816185.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07816185.